Features
-
2012 PharmFree Scorecard
AMSA and the Pew Prescription Project released the 2012 AMSA PharmFree Scorecard this March. The Scorecard is a comprehensive, national overview of all U.S. medical schools and their conflict-of-interest policies.
-
2012 PharmFree Initatives
AMSA calls on medical schools and academic medical centers to implement curricula and policies that prepare students to interact with industry in a way that protects individual patients, promotes public health, and preserves the public trust in medicine.
-
Pharm-Free Family Medicine Residency Survery
A collaboration between AMSA's PharmFree Campaign and Georgetown University Medical Center's PharmedOut
- May 02, 2012 | from New York Times A Sharp Rise in Scientific Journal Retractions NYT Reports scientific retractions are on the rise because of a "dysfunctional scientific climate" that has created a "winner-take-all game with perverse incentives that lead scientists to cut corners and, in some cases, commit acts of misconduct".
- May 02, 2012 | from Georgetown University Medical Center PharmedOut Annual Conferance PharmedOut announces its third annual conference, Missing The Target: When Practitioners Harm More Than Heal, to be held on June 14th and 15th, 2012 at Georgetown University.
- March 31, 2012 | from NEJM Industry Support of CME Are We at the Tipping Point? Although industry support for accredited CME is unlikely to disappear entirely in the near future, a sea change toward greater restriction is beginning to happen as a result of cultural, regulatory, and economic changes and a few courageous acts. CME and health care will be better for it.
AMSA Policy Change Campaign
